Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.

Cytometry - 1 Sept 1994

Maslak P, Hegewisch-Becker S, Godfrey L, Andreeff M

Abstract excerpt

Expression of the multidrug-resistant (MDR) phenotype was investigated in acute leukemia using a monoclonal antibody (HYB-241) directed against a cell surface epitope of the 180 kd P-glycoprotein (gp180) by flow cytometric analysis of clinical samples. Samples from sixty-four patients were tested (37 with acute myelocytic leukemia, 20 with acute lymphocytic leukemia, and 7 with blastic chronic myelocytic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Disease
Share to Adolescent
Share to Aged

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biological Transport

Share to Child, Preschool

Share to Drug Resistance, Multiple

Share to Flow Cytometry

Source

Identifiers

PMID: 8001461
DOI: 10.1002/cyto.990170111

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.PMID 8001461Read ↗

Classical multidrug resistance in acute myeloid leukaemia.Semantic proximity Read ↗

The MDR phenotype in hematologic malignancies: prognostic relevance and future perspectives.Semantic proximity Read ↗

Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]Semantic proximity Read ↗

Expression of the multidrug resistance-associated P-glycoprotein (P- 170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications [see comments]Semantic proximity Read ↗

What does Multidrug Resistance (MDR) Expression Mean in the Clinic?Semantic proximity Read ↗

Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.Semantic proximity Read ↗

The expression of multidrug resistance (MDR) molecule in acute leukemia and lymphoma.Semantic proximity Read ↗

Lack of correlation between expression and function of P-glycoprotein in acute myeloid leukemia cell lines.Semantic proximity Read ↗

Clinical relevance of immunocytochemical detection of multidrug-resistance-associated P-glycoprotein in hematologic malignancies.Semantic proximity Read ↗

Multidrug resistance in the chronic lymphoproliferative disorders.Semantic proximity Read ↗

Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.Semantic proximity Read ↗

Relevance of mdr1 gene expression in acute myeloid leukemia and comparison of different diagnostic methods.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.